Please assess the completion status of the following clinical trial:

Trial Title: Database Surveillance Safety Study of PENTACEL® Vaccine

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: None
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Receipt of DTaP vaccine during the study period by a previously unvaccinated child~Exclusion Criteria:~* None

- Gender: MALE
- Minimum Age: 6 Weeks
- Maximum Age: 24 Months
- Healthy Volunteers: t

Study Arms:
- Pentacel Group (Type: None): Infants initiated on PENTACEL® vaccine
- Other DTap vaccines Group (Type: None): Infants initiated on other DTaP vaccines

Based on this trial design, predict the completion outcome and termination type (if applicable).